Welcome to CDC stacks | Emergency Department Visits by Children and Adolescents for Antipsychotic Drug Adverse Events - 37626 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Emergency Department Visits by Children and Adolescents for Antipsychotic Drug Adverse Events
Filetype[PDF-108.28 KB]


No Related Documents.
You May Also Like:
  1. Emergency Department Visits by Adults for Psychiatric Medication Adverse Events
    Personal Author:
    Hampton, Lee M.; Daubresse, Matthew; Chang, Hsien-Yen; Alexander, G. Caleb; Budnitz, Daniel S.;
    Published:
    Sep 2014
    Source:
    JAMA Psychiatry. 71(9):1006-1014
    Description:
    IMPORTANCE : In 2011, an estimated 26.8 million US adults used prescription medications for mental illness. : OBJECTIVE : To estimate the numbers and rates of adverse drug event (ADE) emergency department (ED) visits involving psychiatric medications...
    File Type:
    Filetype[PDF - 266.84 KB]
  2. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
    Personal Author:
    Shehab, Nadine; Lovegrove, Maribeth C.; Geller, Andrew I.; Rose, Kathleen O.; Weidle, Nina J.; Budnitz, Daniel S.;
    Published:
    Nov 22 2016
    Source:
    JAMA. 316(20):2115-2125
    Description:
    IMPORTANCE : The Patient Protection and Affordable Care Act of 2010 brought attention to adverse drug events in national patient safety efforts. Updated, detailed, nationally representative data describing adverse drug events can help focus these eff...
    File Type:
    Filetype[PDF - 410.15 KB]
  3. Stimulant and Atypical Antipsychotic Medications For Children Placed in Foster Homes
    Personal Author:
    Linares, L. Oriana; Martinez-Martin, Nuria; Castellanos, F. Xavier;
    Published:
    Jan 09 2013
    Source:
    PLoS One. 2013; 8(1).
    Description:
    Objectives : The purpose of this study is to examine the use of prescribed psychoactive medications in a prospective cohort of children shortly after they entered foster homes; and to identify demographics, maltreatment history, psychiatric diagnoses...
    File Type:
    Filetype[PDF - 165.33 KB]
  4. Clinical and economic considerations of antiobesity treatment: a review of orlistat
    Personal Author:
    Zohrabian, Armineh
    Published:
    Jul 05 2010
    Source:
    Clinicoecon Outcomes Res. 2010; 2:63-74.
    Description:
    The objective of this study was to review the current knowledge about the use of orlistat from clinical and economic perspectives, and to assess this drug's public health impact. Weight reduction by current antiobesity drugs, compared to placebo, is ...
    File Type:
    Filetype[PDF - 188.88 KB]
  5. High Prescription Drug Utilization and Associated Costs among Medicaid-eligible Children with Autism Spectrum Disorders Identified by a Population-based Surveillance Network
    Personal Author:
    Logan, Sarah L.; Nicholas, Joyce S.; Carpenter, Laura A.; King, Lydia B.; Garrett-Mayer, Elizabeth; Charles, Jane M.;
    Published:
    Jan 2012
    Source:
    Ann Epidemiol. 2011; 22(1):1-8.
    Description:
    Purpose : This study assessed medication use and associated costs among 8- and 15-yearold children with autism spectrum disorders (ASD) identified by the South Carolina Autism and Developmental Disabilities Monitoring (SCADDM) Network. : Methods : Al...
    File Type:
    Filetype[PDF - 745.27 KB]